Literature DB >> 28303489

In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.

Julie Bolcaen1, Benedicte Descamps2, Marjan Acou3, Karel Deblaere3, Caroline Van den Broecke4, Tom Boterberg5, Christian Vanhove2, Ingeborg Goethals6.   

Abstract

PURPOSE: In this study, the potential of semiquantitative and quantitative analysis of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) was investigated to differentiate glioblastoma (GB) from radiation necrosis (RN) in rats. PROCEDURES: F98 GB growth was seen on MRI 8-23 days post-inoculation (n = 15). RN lesions developed 6-8 months post-irradiation (n = 10). DCE-MRI was acquired using a fast low-angle shot (FLASH) sequence. Regions of interest (ROIs) encompassed peripheral contrast enhancement in GB (n = 15) and RN (n = 10) as well as central necrosis within these lesions (GB (n = 4), RN (n = 3)). Dynamic contrast-enhanced time series, obtained from the DCE-MRI data, were fitted to determine four function variables (amplitude A, offset from zero C, wash-in rate k, and wash-out rate D) as well as maximal intensity (ImaxF) and time to peak (TTPF). Secondly, maps of semiquantitative and quantitative parameters (extended Tofts model) were created using Olea Sphere (O). Semiquantitative DCE-MRI parameters included wash-inO, wash-outO, area under the curve (AUCO), maximal intensity (ImaxO), and time to peak (TTPO). Quantitative parameters included the rate constant plasma to extravascular-extracellular space (EES) (K trans), the rate constant EES to plasma (K ep), plasma volume (V p), and EES volume (V e). All (semi)quantitative parameters were compared between GB and RN using the Mann-Whitney U test. ROC analysis was performed.
RESULTS: Wash-in rate (k) and wash-out rate (D) were significantly higher in GB compared to RN using curve fitting (p = 0.016 and p = 0.014). TTPF and TTPO were significantly lower in GB compared to RN (p = 0.001 and p = 0.005, respectively). The highest sensitivity (87 %) and specificity (80 %) were obtained for TTPF by applying a threshold of 581 s. K trans, K ep, and V e were not significantly different between GB and RN. A trend towards higher V p values was found in GB compared to RN, indicating angiogenesis in GB (p = 0.075).
CONCLUSIONS: Based on our results, in a rat model of GB and RN, wash-in rate, wash-out rate, and the time to peak extracted from DCE-MRI time series data may be useful to discriminate GB from RN.

Entities:  

Keywords:  DCE-MRI; Glioblastoma; Radiation necrosis; Rat model

Mesh:

Substances:

Year:  2017        PMID: 28303489     DOI: 10.1007/s11307-017-1071-0

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  45 in total

1.  Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

Authors:  Mark E Mullins; Glenn D Barest; Pamela W Schaefer; Fred H Hochberg; R Gilberto Gonzalez; Michael H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.

Authors:  L S Hu; L C Baxter; K A Smith; B G Feuerstein; J P Karis; J M Eschbacher; S W Coons; P Nakaji; R F Yeh; J Debbins; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2008-12-04       Impact factor: 3.825

Review 3.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Authors:  Rolf F Barth; Balveen Kaur
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

4.  MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP).

Authors:  Julie Bolcaen; Benedicte Descamps; Karel Deblaere; Tom Boterberg; Giorgio Hallaert; Caroline Van den Broecke; Elke Decrock; Anne Vral; Luc Leybaert; Christian Vanhove; Ingeborg Goethals
Journal:  J Neurooncol       Date:  2014-07-29       Impact factor: 4.130

5.  Evaluation of radiation necrosis and malignant glioma in rat models using diffusion tensor MR imaging.

Authors:  Silun Wang; Yifei Chen; Bachchu Lal; Eric Ford; Erik Tryggestad; Michael Armour; Kun Yan; John Laterra; Jinyuan Zhou
Journal:  J Neurooncol       Date:  2011-09-27       Impact factor: 4.130

6.  Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging.

Authors:  Sotirios Bisdas; Thomas Naegele; Rainer Ritz; Artemisia Dimostheni; Christina Pfannenberg; Matthias Reimold; Tong San Koh; Ulrike Ernemann
Journal:  Acad Radiol       Date:  2011-03-21       Impact factor: 3.173

7.  Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.

Authors:  Amarnath Jena; Sangeeta Taneja; Aashish Gambhir; Anil Kumar Mishra; Maria Mathew Dʼsouza; Sapna Manocha Verma; Puja Panwar Hazari; Pradeep Negi; Ganesh Krishna Rao Jhadav; Shanti Kumar Sogani
Journal:  Clin Nucl Med       Date:  2016-05       Impact factor: 7.794

8.  Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.

Authors:  D Kahn; K A Follett; D L Bushnell; M A Nathan; J G Piper; M Madsen; P T Kirchner
Journal:  AJR Am J Roentgenol       Date:  1994-12       Impact factor: 3.959

9.  The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment.

Authors:  J H Mehrkens; G Pöpperl; W Rachinger; J Herms; K Seelos; K Tatsch; J C Tonn; F W Kreth
Journal:  J Neurooncol       Date:  2008-01-23       Impact factor: 4.130

Review 10.  Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.

Authors:  Anna K Heye; Ross D Culling; Maria Del C Valdés Hernández; Michael J Thrippleton; Joanna M Wardlaw
Journal:  Neuroimage Clin       Date:  2014-09-10       Impact factor: 4.881

View more
  6 in total

1.  Preclinical MRI: Studies of the irradiated brain.

Authors:  Joel R Garbow; Christina I Tsien; Scott C Beeman
Journal:  J Magn Reson       Date:  2018-04-26       Impact factor: 2.229

Review 2.  Magnetic resonance imaging-guided radiation therapy using animal models of glioblastoma.

Authors:  Christian Vanhove; Ingeborg Goethals
Journal:  Br J Radiol       Date:  2019-01-17       Impact factor: 3.039

3.  Dynamic Contrast-Enhanced MRI in Patients with Brain Metastases Undergoing Laser Interstitial Thermal Therapy: A Pilot Study.

Authors:  J I Traylor; D C A Bastos; D Fuentes; M Muir; R Patel; V A Kumar; R J Stafford; G Rao; S S Prabhu
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-01       Impact factor: 3.825

4.  Assessing Tumour Haemodynamic Heterogeneity and Response to Choline Kinase Inhibition Using Clustered Dynamic Contrast Enhanced MRI Parameters in Rodent Models of Glioblastoma.

Authors:  Sourav Bhaduri; Clémentine Lesbats; Jack Sharkey; Claire Louise Kelly; Soham Mukherjee; Arthur Taylor; Edward J Delikatny; Sungheon G Kim; Harish Poptani
Journal:  Cancers (Basel)       Date:  2022-02-26       Impact factor: 6.639

5.  Specific Preoperative Dynamic Contrast-Enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of Glioblastoma Tissue and Predict Recurrence.

Authors:  Mohammed A Azab; Sherief Ghozy; Sherif F Hassanein; Ahmed Y Azzam
Journal:  Cureus       Date:  2021-06-08

6.  MRI analysis to map interstitial flow in the brain tumor microenvironment.

Authors:  Kathryn M Kingsmore; Andrea Vaccari; Daniel Abler; Sophia X Cui; Frederick H Epstein; Russell C Rockne; Scott T Acton; Jennifer M Munson
Journal:  APL Bioeng       Date:  2018-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.